Mannatech Reports $1.0M Net Income in Q1 2026, Reversing Prior Year Loss Amidst Delisting Threat
MTEX is trading near its 52-week low of $4.278 (8.0% above the low).
Summary
Mannatech, facing a delisting threat and "going concern" warning, reported a significant financial turnaround in Q1 2026 with a $1.0 million net income, reversing a prior year loss.
Key Events · Earnings and Guidance · MTEX
-
Return to Profitability
Mannatech reported a net income of $1.0 million ($0.49 per diluted share) for Q1 2026, a significant improvement from a $1.5 million net loss ($0.80 per diluted share) in Q1 2025.
-
Improved Operating Performance
Loss from operations decreased to $0.2 million in Q1 2026, compared to a $0.8 million loss in the prior year period.
-
Cash Position Strengthened
Cash and cash equivalents increased by $0.8 million (13.4%) to $7.0 million as of March 31, 2026.
-
Continued Sales Decline
Net sales for Q1 2026 decreased by $1.6 million to $24.9 million, an 8.1% decline on a constant dollar basis compared to Q1 2025.
Analysis · MTEX · Life Sciences
Mannatech, which recently disclosed a "going concern" warning and received a Nasdaq delisting notice due to negative shareholders' equity, has reported a significant turnaround in its Q1 2026 financial results. The shift from a $1.5 million net loss to a $1.0 million net income provides a crucial positive signal for its immediate financial stability. While sales continue to decline and shareholders' equity remains negative, this return to profitability offers a potential pathway to address its compliance issues and extend its operational runway.
At the time of this filing, MTEX was trading at $4.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.9M. The 52-week trading range was $4.28 to $12.45. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.